Your browser is no longer supported. Please, upgrade your browser.
Settings
DGX Quest Diagnostics Incorporated daily Stock Chart
DGX [NYSE]
Quest Diagnostics Incorporated
IndexS&P 500 P/E15.46 EPS (ttm)8.07 Insider Own0.40% Shs Outstand135.00M Perf Week1.62%
Market Cap16.76B Forward P/E12.41 EPS next Y10.05 Insider Trans-48.43% Shs Float134.10M Perf Month-0.14%
Income1.10B PEG1.59 EPS next Q3.42 Inst Own91.20% Short Float1.85% Perf Quarter12.69%
Sales8.36B P/S2.00 EPS this Y18.70% Inst Trans-0.29% Short Ratio1.91 Perf Half Y5.37%
Book/sh47.41 P/B2.63 EPS next Y-0.35% ROA8.50% Target Price141.81 Perf Year16.49%
Cash/sh11.95 P/C10.44 EPS next 5Y9.72% ROE18.70% 52W Range73.02 - 131.81 Perf YTD16.86%
Dividend2.24 P/FCF15.36 EPS past 5Y10.20% ROI9.40% 52W High-5.32% Beta1.07
Dividend %1.79% Quick Ratio1.30 Sales past 5Y0.80% Gross Margin37.00% 52W Low70.91% ATR3.12
Employees47000 Current Ratio1.40 Sales Q/Q42.40% Oper. Margin18.40% RSI (14)55.32 Volatility1.91% 2.46%
OptionableYes Debt/Eq0.71 EPS Q/Q164.50% Profit Margin13.20% Rel Volume0.31 Prev Close124.33
ShortableYes LT Debt/Eq0.63 EarningsOct 22 BMO Payout26.50% Avg Volume1.30M Price124.80
Recom2.00 SMA200.77% SMA503.91% SMA20011.52% Volume404,797 Change0.38%
Oct-21-20Upgrade Argus Hold → Buy
Jul-29-20Upgrade KeyBanc Capital Markets Sector Weight → Overweight $144
Jul-14-20Upgrade BofA Securities Neutral → Buy $142
Jun-09-20Upgrade Wells Fargo Underweight → Equal Weight $90 → $120
Jun-02-20Upgrade Deutsche Bank Hold → Buy $140
Apr-28-20Upgrade Morgan Stanley Equal-Weight → Overweight $139
Apr-27-20Upgrade Wolfe Research Underperform → Peer Perform
Apr-27-20Upgrade Citigroup Neutral → Buy $113 → $130
Mar-27-20Downgrade Morgan Stanley Overweight → Equal-Weight $95
Jan-08-20Initiated Wells Fargo Underweight $100
Jan-07-20Downgrade Barclays Overweight → Equal Weight $106
Dec-19-19Upgrade BofA/Merrill Underperform → Neutral $94 → $110
Jul-15-19Downgrade Goldman Neutral → Sell $90 → $85
Apr-02-19Upgrade Jefferies Hold → Buy $93 → $107
Mar-18-19Resumed Credit Suisse Neutral $101 → $91
Jan-31-19Downgrade Argus Buy → Hold
Jan-17-19Initiated UBS Neutral $90
Jan-03-19Downgrade BofA/Merrill Neutral → Underperform
Dec-03-18Downgrade BofA/Merrill Buy → Neutral
Nov-30-18Downgrade Goldman Buy → Neutral
Nov-25-20 08:59AM  
Nov-24-20 07:30AM  
Nov-23-20 06:39PM  
06:45AM  
Nov-21-20 11:30AM  
Nov-18-20 06:30PM  
11:06AM  
Nov-17-20 12:06PM  
Nov-13-20 05:58AM  
Nov-11-20 10:28AM  
Nov-03-20 01:58PM  
Nov-02-20 07:47AM  
Oct-28-20 07:30PM  
10:58AM  
10:01AM  
Oct-27-20 11:09AM  
07:30AM  
Oct-26-20 10:05PM  
Oct-24-20 10:04AM  
Oct-22-20 04:34PM  
04:30PM  
02:22PM  
01:14PM  
01:08PM  
01:08PM  
10:43AM  
08:05AM  
07:15AM  
07:08AM  
06:45AM  
Oct-21-20 08:40AM  
Oct-17-20 06:43AM  
01:08AM  
Oct-16-20 09:58AM  
09:57AM  
Oct-15-20 12:31PM  
07:30AM  
07:30AM  
Oct-14-20 07:30AM  
Oct-12-20 05:50PM  
07:20AM  
Oct-11-20 06:07AM  
Oct-07-20 10:26AM  
Oct-06-20 05:45PM  
Oct-05-20 03:15PM  
Oct-02-20 12:10PM  
10:59AM  
Oct-01-20 04:28PM  
Sep-30-20 05:50PM  
03:47PM  
10:41AM  
09:39AM  
09:12AM  
07:30AM  
06:21AM  
Sep-29-20 03:09PM  
Sep-28-20 08:23AM  
Sep-27-20 07:29AM  
Sep-24-20 05:50PM  
12:59PM  
10:42AM  
05:59AM  
Sep-23-20 03:53PM  
11:36AM  
Sep-22-20 12:55PM  
12:34PM  
12:06PM  
11:30AM  
11:06AM  
Sep-17-20 11:44AM  
08:57AM  
08:24AM  
Sep-15-20 05:50PM  
Sep-14-20 09:41AM  
Sep-11-20 02:29PM  
Sep-10-20 10:58AM  
08:37AM  
07:00AM  
06:54AM  
06:45AM  
Sep-09-20 05:45PM  
Sep-08-20 10:24AM  
Sep-07-20 05:10AM  
Sep-03-20 09:32AM  
Sep-02-20 05:45PM  
02:25PM  
Sep-01-20 01:33PM  
08:25AM  
Aug-29-20 07:16AM  
Aug-28-20 11:43AM  
Aug-27-20 04:10PM  
03:40PM  
03:39PM  
Aug-25-20 07:30AM  
Aug-24-20 06:45AM  
Aug-22-20 11:30AM  
Aug-20-20 08:02AM  
Aug-18-20 06:01PM  
11:20AM  
10:42AM  
Quest Diagnostics Incorporated provides diagnostic testing, information, and services in the United States and internationally. The company develops and delivers diagnostic information services, such as routine testing, non-routine and advanced clinical testing, anatomic pathology testing, and other diagnostic information services. It offers diagnostic information services primarily under the Quest Diagnostics brand, as well as under the AmeriPath, Dermpath Diagnostics, Athena Diagnostics, ExamOne, and Quanum brands to patients, clinicians, hospitals, integrated delivery networks, health plans, employers, and accountable care organizations through a network of laboratories, patient service centers, phlebotomists in physician offices, call centers and mobile paramedics, nurses, and other health and wellness professionals. The company also offers risk assessment services for the life insurance industry; and healthcare organizations and clinicians robust information technology solutions. Quest Diagnostics Incorporated has a strategic collaboration with hc1; and strategic relationships with Clinical Genomics Pty Ltd and Anthem Inc. The company was founded in 1967 and is headquartered in Secaucus, New Jersey.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
WILENSKY GAIL RDirectorNov 24Option Exercise57.676,111352,39122,593Nov 27 04:38 PM
WILENSKY GAIL RDirectorNov 24Sale126.026,111770,12016,482Nov 27 04:38 PM
STANZIONE DANIELDirectorNov 23Sale126.3011,2231,417,45928,349Nov 24 04:31 PM
DEPPE MICHAEL JVP, Corp. Controller & CAOOct 21Option Exercise57.2510,450598,24435,485Oct 23 04:42 PM
DEPPE MICHAEL JVP, Corp. Controller & CAOOct 21Sale125.0010,4501,306,25025,090Oct 23 04:42 PM
RUSCKOWSKI STEPHEN HChairman, CEO and PresidentOct 16Option Exercise66.51291,99719,420,720529,744Oct 19 04:17 PM
RUSCKOWSKI STEPHEN HChairman, CEO and PresidentOct 16Sale120.00291,99735,039,640237,747Oct 19 04:17 PM
PREVOZNIK MICHAEL ESVP & General CounselOct 14Option Exercise52.1735,5911,856,60575,678Oct 15 04:45 PM
PREVOZNIK MICHAEL ESVP & General CounselOct 14Sale119.0035,5914,235,32940,087Oct 15 04:45 PM
Doherty Catherine T.SVP, Group Exec. Clin. Fran.Sep 02Option Exercise66.5158,3923,883,652126,803Sep 04 04:18 PM
Doherty Catherine T.SVP, Group Exec. Clin. Fran.Sep 02Sale110.6058,3926,458,34368,411Sep 04 04:18 PM
RING TIMOTHY MDirectorJun 08Option Exercise58.5011,730686,20932,235Jun 10 04:31 PM
GUINAN MARKExecutive Vice President & CFOJun 08Option Exercise71.1772,5965,166,657146,175Jun 10 04:33 PM
GUINAN MARKExecutive Vice President & CFOJun 08Sale117.2372,5968,510,58573,579Jun 10 04:33 PM
RING TIMOTHY MDirectorJun 08Sale116.6011,7301,367,71820,505Jun 10 04:31 PM
RUSCKOWSKI STEPHEN HChairman, CEO and PresidentApr 27Option Exercise71.1711,717833,899249,464Apr 28 04:45 PM
RUSCKOWSKI STEPHEN HChairman, CEO and PresidentApr 27Sale112.0111,7171,312,433237,747Apr 28 04:45 PM
EGLINTON MANNER CARRIESVP, Advanced DiagnosticsApr 27Sale111.025,000555,07522,390Apr 28 04:37 PM
Davis J. E.EVP, General DiagnosticsMar 16Sale87.753,513308,25138,086Mar 17 04:37 PM
PREVOZNIK MICHAEL ESVP & General CounselMar 11Sale104.252,175226,74440,087Mar 12 05:00 PM
Doherty Catherine T.SVP, Group Exec. Clin. Fran.Mar 11Sale104.252,501260,72968,411Mar 12 04:57 PM
RUSCKOWSKI STEPHEN HChairman, CEO and PresidentMar 10Option Exercise71.171007,117237,847Mar 12 04:55 PM
RUSCKOWSKI STEPHEN HChairman, CEO and PresidentMar 10Sale112.1910011,219237,747Mar 12 04:55 PM
RUSCKOWSKI STEPHEN HChairman, CEO and PresidentMar 06Option Exercise71.17230,17816,381,768456,738Mar 10 04:38 PM
RUSCKOWSKI STEPHEN HChairman, CEO and PresidentMar 06Sale112.67230,17825,934,978226,560Mar 10 04:38 PM
PREVOZNIK MICHAEL ESVP & General CounselFeb 27Sale109.0269075,22440,087Feb 28 05:53 PM
Doherty Catherine T.SVP, Group Exec. Clin. Fran.Feb 27Sale109.0278986,01768,411Feb 28 05:51 PM
Davis J. E.EVP, General DiagnosticsFeb 27Sale109.021,100119,92238,105Feb 28 05:50 PM
PREVOZNIK MICHAEL ESVP & General CounselFeb 26Sale111.0932135,66041,445Feb 28 05:53 PM
Doherty Catherine T.SVP, Group Exec. Clin. Fran.Feb 26Sale111.0936840,88169,977Feb 28 05:51 PM
Davis J. E.EVP, General DiagnosticsFeb 26Sale111.0951056,65640,392Feb 28 05:50 PM
Davis J. E.EVP, General DiagnosticsFeb 25Sale112.7359867,41341,454Feb 26 04:34 PM
Doherty Catherine T.SVP, Group Exec. Clin. Fran.Feb 25Sale112.7340545,65670,701Feb 26 04:31 PM
Davis J. E.EVP, General DiagnosticsJan 02Option Exercise68.64143,5469,853,318180,080Jan 03 04:39 PM
Davis J. E.EVP, General DiagnosticsJan 02Sale105.57143,53715,153,86436,543Jan 03 04:39 PM